طراحی الگوی فرآیند تجاری‌سازی فناوری، با تمرکز بر صنعت دارو و فراورده‌های بیولوژیک با استفاده از رویکرد فراترکیب

نوع مقاله : مقاله کامل

نویسندگان

1 گروه کارآفرینی، واحد قزوین، دانشگاه آزاد اسلامی، قزوین، ایران

2 گروه کارآفرینی، دانشکده کارافرینی، دانشگاه تهران، تهران، ایران

چکیده

   توسعه صنعت دارویی هر کشوری، نشان‌دهنده توانمندی آن کشور در حوزه تأمین بهداشت و سلامت افراد آن جامعه است. با توجه به تحولات این صنعت در تعامل با دستاوردهای علم زیست فناوری و اهمیتی که زیست داروها در درمان بیماری‌های خاص در جوامع دارند، بررسی فرآیند تجاری‌سازی نقش مهمی در ارائه سریع‌تر داروها به بازار دارد. هدف این پژوهش طراحی الگوی فرآیند تجاری‌سازی فناوری، با تمرکز بر صنعت دارو و فراورده‌های بیولوژیک می‌باشد. روش پژوهش کیفی و از نوع فراترکیب است که برای گردآوری داده‌ها از روش کتابخانه‌ای استفاده شده است. جمعیت مورد مطالعه‌ی پژوهش را تمامی مقاله‌های مرتبط با موضوع پژوهش شامل می‌شود. در راستای انجام پژوهش پس از طراحی سؤالات پژوهش، جستجویی نظام‌مند براساس کلید واژه‌های مرتبط- مدل‌های تجاری‌سازی، صنعت دارو- از پایگاه‌های داده Scopus ،Civilica ،SID ،IRANDOC ،ISC ،Emerald ،IEEE ،Science Direct صورت گرفته است. با بررسی مقاله‌ها و مدل‌های تجاری‌سازی، 9 بعد به‌عنوان ابعاد فرآیند تجاری‌سازی فناوری، با تمرکز بر صنعت دارو و فراورده‌های بیولوژیک شناسایی شده است. براساس این ابعاد مدل یکپارچه نهایی ارایه و اعتبارسنجی شده است. این مقاله با شناسایی ابعاد فرآیند تجاری‌سازی فناوری، با تمرکز بر صنعت دارو و فراورده‌های بیولوژیک؛ می‌تواند الگوی مناسبی برای استفاده در صنعت داروی کشور باشد.

کلیدواژه‌ها


عنوان مقاله [English]

Designing a technology commercialization process model, focusing on the pharmaceutical and biological products industry using a hybrid approach

نویسندگان [English]

  • M Kavei 1
  • H. Sadeghi 2
  • M Azizi 2
1 Department of Entrepreneurship, Qazvin Branch, Islamic Azad University, Qazvin, Iran
2 Department of Entrepreneurship, Faculty of Entrepreneurship, University of Tehran, Tehran, Iran
چکیده [English]

The development of the pharmaceutical industry of any country shows the capability of that country in the field of health and well-being of the people of that society. Given the developments in this industry in interaction with the achievements of biotechnology and the importance of biomedicines in the treatment of certain diseases in societies, the study of the commercialization process has an important role in faster delivery of drugs to the market. The purpose of this study is to design a model for the process of commercialization of technology, focusing on the pharmaceutical industry and biological products. The research method is qualitative and meta-combined, which has been used as a library method to collect data. The study population includes all articles related to the research topic. In order to conduct research after designing research questions, a systematic search has been conducted based on related keywords - commercialization models, pharmaceutical industry - from Scopus, Civilica, SID, IRANDOC, ISC, Emerald, IEEE, Science Direct databases. By reviewing commercialization articles and models, 9 dimensions have been identified as dimensions of the technology commercialization process, focusing on the pharmaceutical and biological products industries. Based on these dimensions, the final integrated model has been presented and validated. This article identifies the dimensions of the technology commercialization process, focusing on the pharmaceutical and biological products industry; it can be a good model for use in the country's pharmaceutical industry.

کلیدواژه‌ها [English]

  • Commercialization
  • Technology
  • Pharmaceutical industry
  • Biological products
1- Delavar, Atieh, Mohammadi, Mehdi, Salami, Reza and Manteghi Manouchehr (2012) The process of commercialization of products with advanced technology (Case study in commercial aircraft) Management Improvement Quarterly, Year 6, Issue1.
2-Goodarzi, Mehdi, Bamdad, Sufi, Jahanyar, Arabi, Seyed Mohammad, Amir Maghsoud (2011) Model of technology commercialization process in Iranian government research institutes, Journal of Science and Technology Policy, Fourth Year, No. 2.
3-Matin, Aida, Mohammadzadeh, Shadi, (2013) A Review of Linear Commercialization Models, Technology Growth, No. 36
4-Mosaei, Ahmad, Sadraei, Nouri, Sasan, Bandarian, Reza (2008) Model of the process of commercialization of technical knowledge of chemical products,Technology Growth, Volume 4, Number 16. 
5- Alam, I. Perry, C. (2002). A customer – oriented new service development process. Journal of Sevice Marketing, Vol. 16. No.6, pp. 515-534.
6- APCTT, A. P. (2005). The hand book of technology transfer – chapter 2: technology commercialization. URL: http://www.technology4sme. net/tech_handbook.aspx.
7- Beck, j. (2002). Mthering multiples: A meta-synthesis of the qualitativereserch.MCN. Teh American Juornal of Maternal/child Nursing. 93.
8- Booz, Allen, Hamilton. (1982) New products management for the 1980s, New York: Booz, Allen & Hamilton, Inc.
9- Champion, D. (2001). Mastering the Value Chain. Harvard Business Review. Vol. 79, Iss. 6, 108-115.
10- Cooper, R. G. (1994). Perspective third generation new product processes. Journal of Product Innovation Management. Vol. 11, pp.3-14.
11- Charttirot, K. Natcha, T. and Achara, C. (2014). Evaluation model for research and development commercialization capability.
12- Dai, Y. Gurau, C. & Ranchhod, A. (2006). Open innovation in the UK biopharmaceutical industry. 8th session on: Innovation in the extended enterprise. July 5th-8th, Brindisi, Ital 3-6.
13- Daly, P. (1985). The Biotechnology Business: A Strategic Analysis. London: Francis Pinter.
14- Degeeter, M.J. (2004). Technology commercialization manual: strategy, tactics and economics for business success [online].
15- Diane, A. I. (2004). S&T Commercialization of Federal Research Laborites and University Research, Carleton University, Eric Sport School of Business, Canada.
16- EFPIA. 2011. Code of practice on relationships between the pharmaceutical industry and patient organisation. The European federation of pharmaceutical Industries and Associations. 4-8.
17- Edgett, S. J. (1996). The new product development process for Commercial financial services. Industrial Marketing Mangement, Vol. 23. pp. 507-515.
18- Ferguson, G. (2008). Commercialisation Models – a review of the literature on existing commercialisation models. Rumour Control Consultancy, Available at: http://rumourcontrol.com.au/?page_id=40.
20- Finfgeld, D. L. (2003). Meta synthesis: The state of the art—so far. Qualitative Health Research, 13: 893-904.
21- Gibson, M. (2009). Pharmaceutical Preformulation and Formulation. By Informa Healthcare USA, Inc: 245-48.
22- Goldsmith, R. (2003). Model of Commercialization. available online at: http:// asbdc.ualr.edu/technology/commercialization/the_model.asp.
23- Göktepe, D. (2004). Investigation of University Industry Technology Transfer Cases: A Conceptual and Methodological Approach, Division of Innovation-LTH Lund University.
24- Goudarzi, M. (2012). Technology commercialization model of iranian governmental research institutions. Tehran: s.n.
25- Industry Canada (2006). People and Excellence: the Heart of Successful Commercialization- Volume II, Supporting Material. People and Excellence: The Heart of Successful Commercialization. Ottawa, Industry Canada.
26- Lemmetyinen, uha. (2001). Commercialization of biopharmaceuticals, master’s thesis submitted in partial fulfillment of the requirements for the degree of Master of Science in Economics, Lappeenranta University of technology. Helsinki.125-27.
27- Magnus, K. (2004). commercialization of research results in the united states, ITPS, Swedish Institute for growth policy studies, P.14,15, Accessed in www.itps.se.
28- Mehta, S. S. (2008). Commercializing successful biomedical technologies: basic principles for the development of drugs, diagnostics and devices. Cambridge University Press. 42-3.
29- Mahmodpoor B. et al. (2011). Identification of commercialization challenges of humanities researches and presentation a grounded theory. Journal of Innovation and Creativity in Human Science, No. 2, pp. 19-48, [in Persian].
30- Minseo, K. Hyesu, P. Yeong-wha, S. and Sun-young, P. (2019). bridging the Gap in the Technology Commercialization Process: Using a Three-Stage Technology–Product–Market Model Department of Management of Technology, School of Business, Konkuk University, 05029 Seoul, Korea;mskim.konkuk@gmail.com (M.K.); hsmot@konkuk.ac.kr (H.P.); sawng@konkuk.ac.kr (Y.-w.S.).
31- Nassiri-Koopaei, N. Majdzadeh, R. (2014). Commercialization of biopharmaceutical knowledge in Iran; challenges and solutions. DARU Journal of Pharmaceutical Sciences. 22:29.
32- Porter, M. (2011). Value Chain model framework, value Based Management. Retrieved 12-5-2013 from: http://www.valuebasedmanagement.net/methods_porter_value_chain.html.
33- Reamer, A. & Others. (2003). Technology transfer and commercialization :their role in economic development. Economic development administration,U.S.department of commerce.
34- Roppe, T. (1999). Land see raus mark kinointi. porvoo: WSOY. 236-9.
35- Rosa, J. Rose, A. (2007). Report on Interviews on the Commercialisation of Innovation. Ottawa, Science, innovation and Electronic Information Division, Statistics Canada. 8-15. 
36- Rothwell, R. Zegveld, W. (1985). Reindustrialization and Technology. Longman, Harlow.
37- Sandelowski, M. Barroso, J. (2007). Handbook for Synthesizing Qualitative Research, New York: Springer.
38- Snehal, T. Ruchita, G. and Karuna, J. (2019). Development of a Technology Commercialization Model for Indian Biotechnology Firms.
39- Shakeel, s. Takala, j. Zhu, l. (2017). Commercialization of renewable energy technologies: A ladder building approach, Renewable and Sustainable Energy Reviews 78, 855–867.
40- Scheuing, E. E. & Johson, M. (1989). A proposed model for new service development. The Journal of Service marketing, Vol. 3, No. 2, pp. 25-34.
41- Shekar, A. (2007). An innovative model of service development: A process guide for service managers; The Public Sector Innovation Journal, Vol. 12(1), pp.2-18.
42- Thanh Huyen, T. T. (2009). A Study of the Key Success Factors for New Technology Commercialization. Master’s thesis, National Cheng Kung University, Available at: http://etds. lib. ncku. edu. tw.
43- Touhill, C. Joseph, Touhill, Gregory J. and O'Riordan, Thomas A. (2008). Commercialization of Innovative Technologies, John Wiley & Sons, Inc.
44- Vernalls, S. (2012). New Drug Development In Biopharmaceutical Companies: The Role of Private and External Funding. Bachelor's thesis in International Business Management, Turku University Of Applied Sciences.
45- Walsh, V. (1993). Demand, public markets and innovation in biotechnology, Science and Public Policy. 20(3): 143-47.
46- Wikipedia. 2013. The european federation of pharmaceutical Industries and Associations. https://en.wikipedia.org/wiki/European_Federation_of_Pharmaceutical_Industries_and_Associations. 1-2.
47- Zimmer, L. (2006). Qualitative meta-synthesis: a question of dialoguing with texts. Journal of Advanced Nursing. 53: 311–318.